Racing Post22h
A jockey worth his claim, a 33-1 Gold Cup contender and a Cromwell stunner
Speaking of Cromwell, saddling the 1-2-3 in the Dan & Joan Moore Memorial Handicap Chase was a remarkable feat, and ...
PharmiWeb7h
GSK enters agreement to acquire IDRx, Inc.
GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will ...
FierceBiotech10h
JPM25: Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard of care
In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal ...
Immuneering Provides Positive Update on Phase 2a Arm Studying IMM-1-104 in Combination with Modified FOLFIRINOX for First-Line Pancreatic Cancer
Two new partial responses (PRs) reported in Phase 2a arm studying IMM-1-104 in combination with modified FOLFIRINOX (mFFX) in ...
Below Market Value16h
Letting agents express concerns over the Renters’ Rights Bill
Propertymark warns of potential administrative burdens and market disruption as the Renters’ Rights Bill returns to ...
Pharmabiz8h
GSK to acquire Boston-based, clinical-stage biopharma company, IDRx for up to $1.15 billion
GSK to acquire Boston-based, clinical-stage biopharma company, IDRx for up to $1.15 billion: London, UK Monday, January 13, 2025, 13:35 Hrs [IST] GSK plc and IDRx, Inc. (IDRx) ann ...